LIFEPAK 35 monitor/defibrillator
Physio-Control, Inc. · Decision date Sep 2, 2026
What did the FDA approve?
FDA approved supplement S069 to PMA P160026 for the LIFEPAK 35 monitor/defibrillator on September 2, 2026. The supplement describes a minor design change to the EtCO2 module of the LIFEPAK35. The applicant is Physio-Control, Inc., and the supplement type is Real-Time Process, with the stated reason being a change to design, components, specifications, or material.
This supplement is not a new approval of the entire system; it addresses only the EtCO2 module change under the existing PMA. The device category is automated external defibrillators (non-wearable), product code MKJ, specialty cardiovascular. The source statement does not specify the exact nature of the design change, any testing performed, or any clinical or safety outcomes. The reported purpose is distinct from independent proof of safety or clinical effectiveness.
FDA approval order statement
a minor design change to the EtCO2 module of the LIFEPAK35
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 2, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160026/S069
- Regulatory pathway
- PMA supplement
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- Decision code
- APPR
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160026 · Original PMA
LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE
P160026/S069 received
Application receipt date recorded by FDA.
P160026/S069 · FDA decision
Real-Time Process
P160026/S073 · Related supplement
LIFEPAK 15 monitor/defibrillator
P160026/S074 · Related supplement
LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE
P160026/S076 · Related supplement
LIFEPAK 35 monitor/defibrillator
Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160026
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Physio-Control, Inc. | PMA approval | Jul 2, 2018 | FDA | |
LIFEPAK 15 monitor/defibrillatorP160026/S073 | Physio-Control, Inc. | PMA supplement | Sep 10, 2026 | FDA |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| ZOLL MEDICAL CORPORATION | PMA approval | Dec 27, 2017 | FDA | |
| ZOLL MEDICAL CORPORATION | PMA approval | May 26, 2017 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Physio-Control, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 11811 Willows Rd. NE, Redmond, WA, 98052
Sources and methodology
- Original FDA record: P160026/S069
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




